NAICS Code 622310-05 - Cancer Treatment Centers

Marketing Level - NAICS 8-Digit

Business Lists and Databases Available for Marketing and Research

Total Verified Companies: 1,597
Contact Emails: 7,770
Company Websites: 1,478
Phone Numbers: 1,530
Business Addresses: 1,597
Companies with Email: 532
Get Business List
NAICS CODE 622310-05
Reach new customers, connect with decision makers, and grow your business.
Pricing from $0.05 to $0.25 per lead
Ideal for: Direct Mailing Email Campaigns Calling Market Research ‐ Free Sample & Report, Custom Lists, and Expert Support — All Included
Looking for more companies? See NAICS 622310 - Specialty (except Psychiatric and Substance Abuse) Hospitals - 1,890 companies, 16,960 emails.

NAICS Code 622310-05 Description (8-Digit)

Cancer Treatment Centers are specialized hospitals that provide diagnosis, treatment, and care for patients with cancer. These centers offer a range of services, including chemotherapy, radiation therapy, surgery, and other supportive therapies. Cancer Treatment Centers employ a team of medical professionals, including oncologists, radiologists, surgeons, nurses, and other specialists who work together to provide comprehensive care to cancer patients. These centers also conduct research and clinical trials to develop new treatments and improve patient outcomes.

Parent Code - Official US Census

Official 6‑digit NAICS codes serve as the parent classification used for government registrations and documentation. The marketing-level 8‑digit codes act as child extensions of these official classifications, providing refined segmentation for more precise targeting and detailed niche insights. Related industries are listed under the parent code, offering a broader context of the industry environment. For further details on the official classification for this industry, please visit the U.S. Census Bureau NAICS Code 622310 page

Tools

Tools commonly used in the Cancer Treatment Centers industry for day-to-day tasks and operations.

  • Linear accelerators
  • CT scanners
  • MRI machines
  • PET scanners
  • Ultrasound machines
  • Endoscopes
  • Biopsy needles
  • Surgical instruments
  • Chemotherapy drugs
  • Radiation therapy equipment

Industry Examples of Cancer Treatment Centers

Common products and services typical of NAICS Code 622310-05, illustrating the main business activities and contributions to the market.

  • Radiation therapy
  • Chemotherapy
  • Surgical oncology
  • Hematology
  • Immunotherapy
  • Palliative care
  • Clinical trials
  • Cancer research
  • Genetic counseling
  • Pain management

History

A concise historical narrative of NAICS Code 622310-05 covering global milestones and recent developments within the United States.

  • The history of the Cancer Treatment Centers industry dates back to the early 20th century when radiation therapy was first introduced as a treatment for cancer. In 1913, the first cancer hospital was established in the United States, and by the 1930s, radiation therapy had become a widely accepted treatment for cancer. In the 1950s, chemotherapy was introduced, and by the 1970s, the first bone marrow transplant was performed. In the 1980s, the use of monoclonal antibodies was introduced, and in the 1990s, the first targeted therapy was approved for the treatment of cancer. In recent years, the industry has seen significant advancements in immunotherapy, precision medicine, and gene therapy, which have revolutionized cancer treatment. In the United States, the Cancer Treatment Centers industry has experienced significant growth in recent years. According to the National Cancer Institute, the number of cancer survivors in the United States increased from 3 million in 1971 to 16.9 million in 2019. This growth can be attributed to several factors, including advancements in cancer treatment, early detection, and an aging population. In addition, the Affordable Care Act has increased access to cancer treatment for millions of Americans. Despite these advancements, cancer remains a leading cause of death in the United States, and the industry continues to face challenges in providing affordable and accessible cancer treatment to all Americans.